A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Clinical trial NCT07341828 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07341828
Sponsor: Huashan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis Stiff Person Syndrome

Start date: 2026-02-01
Primary completion: 2027-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.